Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06408662 · ClinicalTrials.gov registry record · NA

Remote Delivery of a Mindfulness-based Intervention for Tics

A NA study of Tourette Syndrome and Tic Disorders, sponsored by Johns Hopkins University.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT06408662: Recruiting NA study of Tourette Syndrome and Tic Disorders, sponsored by Johns Hopkins University.

NCT06408662 is a NA study of Tourette Syndrome and Tic Disorders that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 150 participants, above the 82-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (83% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06408662, a NA study of Tourette Syndrome and Tic Disorders, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

This research study is being done to compare a mindfulness-based intervention for tics (MBIT) to psychoeducation with relaxation and supportive therapy (PRST) for individuals with Tourette's syndrome or Persistent Tic Disorders (collectively TS). It is the investigator's hope that this information cam be used to improve current treatments for individuals with TS.

Primary Outcome

The YGTSS is a clinician-administered measure of tic symptom severity (0-50) and impairment (0-50). Greater scores are reflective of greater severity and/or impairment.

Interventions

  • OTHER mindfulness-based intervention for tics (MBIT)
  • OTHER psychoeducation with relaxation and supportive therapy (PRST)

Study Locations (1)

Maryland

  • Johns Hopkins University School of Medicine - Baltimore

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2024-05-23
Est. Completion 2028-12
Phase NA
Johns Hopkins University

1,448 total trials

What NCT06408662 shows while recruiting

NCT06408662 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, above the 82-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (83% higher).

The record links to 8 conditions, with Tourette Syndrome appearing as the primary indexed condition, and to 2 interventions - of which mindfulness-based intervention for tics (MBIT) is the first listed.

NCT06408662 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT06408662 about?

NCT06408662 is a clinical study titled "Remote Delivery of a Mindfulness-based Intervention for Tics". This research study is being done to compare a mindfulness-based intervention for tics (MBIT) to psychoeducation with relaxation and supportive therapy (PRST) for individuals with Tourette's syndrome or Persistent Tic Disorders (collectively TS). It is the investigator's hope that this information c...

What is the current status of trial NCT06408662?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2024-05-23. Estimated completion is 2028-12.

What conditions does trial NCT06408662 study?

This clinical trial studies the following conditions: Tourette Syndrome, Tic Disorders, Tourette's Disorder, Chronic Motor Tic Disorder, Chronic Vocal Tic Disorder.

What interventions are being tested in trial NCT06408662?

The interventions under investigation include: mindfulness-based intervention for tics (MBIT) (OTHER), psychoeducation with relaxation and supportive therapy (PRST) (OTHER).

Who is sponsoring clinical trial NCT06408662?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06408662 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tourette Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06408662's enrollment target sits among peer trials

150 7th of 33 higher than 26 of 33 other Tourette Syndrome trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Tourette Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06408662, the US trial registry maintained by the National Library of Medicine. NCT06408662 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.